Samsung commissions semiconductor safety study
Samsung Electronics said Thursday it has commissioned an independent health and safety review of its semiconductor factories in South Korea after employee illnesses and deaths raised fears of cancer risks.
The yearlong investigation will be carried out by an independent team of leading occupational health and safety experts “who will be given complete access to Samsung’s semiconductor manufacturing facilities,” the company said in a statement.
Samsung Electronics Co. announced in April that it planned such a study. It has been attempting to allay public anxieties after a January lawsuit against a government agency involving six people who developed leukemia and lymphoma they claim was caused by exposure to radiation and the carcinogen benzene in the company’s chip factories.
Suwon, South Korea-based Samsung said at the time that 22 chip plant workers were diagnosed with leukemia or lymphoma and that 10 died between 1998 and this year. It also said that there was no risk of contracting cancer at its semiconductor facilities.
The company, a major force in the global electronics industry, is the world’s largest manufacturer of computer memory chips, flat screen televisions and liquid crystal displays.
“We have assembled a group of well-respected international experts to ensure this is an objective and transparent review,” Cho Soo-in, president of Samsung’s memory division, said in the statement. “We want to ensure this process addresses any questions about the safety of our semiconductor manufacturing facilities.”
Samsung said that the review will be led by Environ International, which it described as an international environment and health consultancy. It said it would be carried out in consultation with experts from academic institutions including the Harvard University School of Public Health.
The investigation will consist of a “complete review that will evaluate general health and safety risks and hazards, use of carcinogenic substances, potential correlations between the workplace and employee illnesses, and other areas that may be independently identified by the inspection team,” the statement said.
Samsung took the initiative in discussing the cancer issue following the March 31 death of Park Ji-yeon, a 23-year-old woman who worked at a Samsung chip plant and had leukemia. She was a plaintiff in the lawsuit.
Chip manufacturing requires numerous chemicals. Benzene has been frequently used as a solvent in the industry, though Samsung says it has never employed it.
Supporters of the lawsuit have held small, yet vocal, demonstrations in front of Samsung’s Seoul headquarters building as well as at a chip plant south of the capital over the cancer concerns.
- What cybersecurity trends are expected in 2023?
- Emerging as the Hare in 2023 and Beyond – Fighting age-old criticism of automation
- DHL: Recalibrating logistics, supply chains in a post-Covid era
- Rockwell Automation is striving in SEA, with huge potential in Vietnam, Malaysia
- Data protection is vital: 85% of Singaporeans concerned about how companies use their data